Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs NRG Energy Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while NRG Energy Inc trades at $99.56 (market cap $22.53B). The key difference: NRG Energy Inc is far larger — about 5.4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and NRG Energy Inc pays a 1.77% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and NRG Energy Inc for 63 Days on average.
| INDV | NRG | |
|---|---|---|
Market Cap | $4.18B | $22.53B |
Volume | 1,819,746 | 2,965,287 |
Sector | Health | Utilities |
52-Week High | $41.83 | $184.03 |
52-Week Low | $24.09 | $95.23 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $4.47B | $46.49B |
Dividend Yield | — | 1.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NRG Energy trades at $100.85, down 5.19% on the day amid mixed earnings results, with recent Q1 and Q2 2026 EPS misses. The stock shows neutral technical signals with bearish moving averages, while fundamentals reflect strong revenue growth to $30.71B in 2025 and a solid ROE of 26.77%, though net margins are thin at 2.56%. Recent news highlights a major 1.2 GW Texas data-center power project as a growth driver.
Outlook is cautiously optimistic given analyst consensus favoring Buy (70.37%) and a $202.90 price target, implying significant upside. Key risks include execution on large capex projects, rising debt-to-asset ratio (56.42% in 2025), and competitive pressures in utilities. The stock offers value with a low P/S of 0.66 but requires monitoring of earnings consistency and leverage trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
